These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7889968)

  • 1. Treatment of cerebrospinal fluid shunt infections with teicoplanin.
    Fernández Guerrero ML; de Górgolas M; Fernández Roblas R; Campos JM
    Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1056-8. PubMed ID: 7889968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis].
    Jourdan C; Convert J; Peloux A; Boussaid O; Grando J; Tigaud S
    Pathol Biol (Paris); 1996 May; 44(5):389-92. PubMed ID: 8758482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis.
    Nava-Ocampo AA; Mojica-Madera JA; Villanueva-García D; Caltenco-Serrano R
    Ther Drug Monit; 2006 Jun; 28(3):474-6. PubMed ID: 16778737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid penetration and bacteriostatic activity of linezolid against Enterococcus faecalis in a child with a ventriculoperitoneal shunt infection.
    Milstone AM; Dick J; Carson B; Siberry GK
    Pediatr Neurosurg; 2007; 43(5):406-9. PubMed ID: 17786008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycopeptides (vancomycin, teicoplanin)--their place in the antibacterial therapy of patients in a high-risk group].
    Beloborodova NV
    Anesteziol Reanimatol; 1998; (4):23-7. PubMed ID: 9770813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin in gram-positive infection: microbiological aspects.
    Spencer RC
    Eur J Haematol Suppl; 1993; 54():6-9. PubMed ID: 8365463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro selection of resistance to vancomycin and teicoplanin in Enterococcus faecium and Enterococcus faecalis compared with Staphylococcus epidermidis.
    Markopulos E; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 1998 Jan; 41(1):43-7. PubMed ID: 9511036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intraventricularly administered teicoplanin in Staphylococci ventriculitis.
    Beenen LF; Touw DJ; Hekker TA; Haring DA
    Pharm World Sci; 2000 Aug; 22(4):127-9. PubMed ID: 11103381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teicoplanin for treating enterococcal infective endocarditis: A retrospective observational study from a referral centre in Spain.
    Escolà-Vergé L; Fernández-Hidalgo N; Rodríguez-Pardo D; Pigrau C; González-López JJ; Bartolomé R; Almirante B
    Int J Antimicrob Agents; 2019 Feb; 53(2):165-170. PubMed ID: 30315920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of ventriculitis and central nervous system shunt infection by Staphylococcus epidermidis with vancomycin by intraventricular injection in a liver transplant recipient.
    Schwabe M; Jüttner E; Blaich A; Potthoff K; Pisarski P; Waller CF
    Transpl Infect Dis; 2007 Mar; 9(1):46-50. PubMed ID: 17313472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections.
    Cruciani M; Navarra A; Di Perri G; Andreoni M; Danzi MC; Concia E; Bassetti D
    Clin Infect Dis; 1992 Aug; 15(2):285-9. PubMed ID: 1387805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin in the therapy of staphylococcal neuroshunt infections.
    Maserati R; Cruciani M; Azzini M; Carnevale C; Suter F; Concia E
    Int J Clin Pharmacol Res; 1987; 7(3):207-13. PubMed ID: 2954919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy of intraventricularly administered vancomycin in the case of central nervous system infection caused by enterococcus faecalis].
    Czaban SL; Lebkowski WJ; Krajewski JP; Borkowski J
    Wiad Lek; 2002; 55(9-10):617-25. PubMed ID: 12607418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
    Tush GM; Huneycutt S; Phillips A; Ward JD
    Clin Infect Dis; 1998 Jun; 26(6):1460-1. PubMed ID: 9636880
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents.
    Losonsky GA; Wolf A; Schwalbe RS; Nataro J; Gibson CB; Lewis EW
    Clin Infect Dis; 1994 Jul; 19(1):163-5. PubMed ID: 7948523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
    Arnell K; Enblad P; Wester T; Sjölin J
    J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant Enterococcus faecalis.
    Branley J; Yan B; Benn RA
    Med J Aust; 1996 Sep; 165(5):292. PubMed ID: 8816690
    [No Abstract]   [Full Text] [Related]  

  • 18. [First case of infection due to vancomycin resistant Enterococcus faecalis in New Caledonia].
    Garin B; Barny S; Lechevallier S; Agathe-Nerine J
    Med Mal Infect; 2006 May; 36(5):297-8. PubMed ID: 16631333
    [No Abstract]   [Full Text] [Related]  

  • 19. Serial cytokine profiles in shunt-related ventriculitis treated with intraventricular vancomycin.
    Laborada G; Cruz F; Nesin M
    Chemotherapy; 2005 Oct; 51(6):363-5. PubMed ID: 16227692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.